Schefold et al., in a cohort of patients with moderate to severe CKD, observed that IDO activity increased in association with the severity of the CKD (not influenced by hemodialysis treatment) and it positively correlated with markers of inflammation [8]. Here, IDO1 is linked to chronic kidney disease.